Decreased proliferation of human melanoma cell lines caused by antisense RNA against translation factor eIF-4A1

Bernstein J, Sella O, Le SY and Elroy-Stein O (1997) PDGF2/c-sis mRNA leader contains a differentiation-linked internal ribosomal entry site (D-IRES). J Biol Chem 272: 9356–9362

Birnboim HC and Doly J (1979) A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucl. Acids Res 7: 1513–1523

Caraglia M, Budillon A, Vitale G, Lupoli G, Tagliaferri P and Abbruzzese A (2000) Modulation of molecular mechanisms involved in protein synthesis machinery as a new tool for the control of cell proliferation. Eur J Biochem 267: 3919–3936

Carey TE, Takahashi T, Resnick LA, Oettgen HF and Old LJ (1976) Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells. Proc Natl Acad Sci USA 73: 3278–3282

Citro G, D'Agnano I, Leonetti C, Perini R, Bucci B, Zon G, Calabretta B and Zupi G (1998) c-myc antisense oligodeoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice. Cancer Res 58: 283–289

Clemens MJ and Bommer UA (1999) Translational control: the cancer connection. Int J Biochem Cell Biol 31: 1–23

Crooke ST (1999) Molecular mechanisms of action of antisense drugs. Biochim Biophys Acta 1489: 31–44

Dean NM, McKay R, Condon TP and Bennett CF (1994) Inhibition of protein kinase C-alpha expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters. J Biol Chem 269: 16416–16424

De Wet JR, Wood KV, DeLuca M, Helinski DR and Subramani S (1987) Firefly luciferase gene: structure and expression in mammalian cells. Mol Cell Biol 7: 725–737

Donze O, Jagus R, Koromilas AE, Hershey JW and Sonenberg N (1995) Abrogation of translation initiation factor eIF-2 phosphorylation causes malignant transformation of NIH 3T3 cells. EMBO J 14: 3828–3834

Eberle J, Garbe C and Orfanos CE (1995a) Identification of genes specifically regulated in human melanoma cells. Arch Dermatol Res 287: 421–427

Eberle J, Garbe C, Wang N and Orfanos CE (1995b) Incomplete expression of the tyrosinase gene family (tyrosinase, TRP-1 and TRP-2) in human malignant melanoma cells in vitro. Pigment Cell Res 8: 307–313

Eberle J, Krasagakis K and Orfanos CE (1997) Translation initiation factor eIF-4A1 mRNA is consistently overexpressed in human melanoma cells in vitro. Int J Cancer 71: 396–401

Eberle J, Weitmann S, Thieck O, Pech H, Paul M and Orfanos CE (1999) Downregulation of endothelin B receptor in human melanoma cell lines parallel to differentiation genes. J Invest Dermatol 112: 925–932

Kozak M (1991) An analysis of vertebrate mRNA sequences: intimations of translational control. J Cell Biol 115: 887–903

Gillies RJ, Didier N and Denton M (1986) Determination of cell number in monolayer cultures. Anal Biochem 159: 109–113

Gossen M and Bujard H (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 89: 5547–5551

Graff JR, Boghaert ER, De Benedetti A, Tudor DL, Zimmer CC, Chan SK and Zimmer SG (1995) Reduction of translation initiation factor 4E decreases the malignancy of ras-transformed cloned rat embryo fibroblasts. Int J Cancer 60: 255–263

Grossman D, McNiff JM, Li F and Altieri DC (1999) Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma. J Invest Dermatol 113: 1076–1081

Jagus R, Joshi B and Barber GN (1999) PKR, apoptosis and cancer. Int J Biochem Cell Biol 31: 123–138

Jansen B, Wacheck V, Heere-Ress E, Schlagbauer-Wadl H, Hoeller C, Lucas T, Hoermann M, Hollenstein U, Wolff K and Pehamberger H (2000) Chemosensitisation of malignant melanoma by BCL2 antisense therapy. Lancet 356: 1728–1733

Kerekatte V, Smiley K, Hu B, Smith A, Gelder F and De Benedetti A (1995) The proto-oncogene/translation factor eIF4E: a survey of its expression in breast carcinomas. Int J Cancer 64: 27–31

Kim NS, Kato T, Abe N and Kato S (1993) Nucleotide sequence of human cDNA encoding eukaryotic initiation factor 4AI. Nucl Acids Res 21: 2012

Lazaris-Karatzas A, Montine KS and Sonenberg N (1990) Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap. Nature 345: 544–547

Lockshin A, Giovanella BC, De Ipolyi PD, Williams Jr LJ, Mendoza JT, Yim SO and Stehlin JSJ (1985) Exceptional lethality for nude mice of cells derived from a primary human melanoma. Cancer Res 45: 345–350

MacDonald RJ, Swift GH, Przybyla AE and Chirgwin JM (1987) Isolation of RNA using guanidinium salts. Methods Enzymol 152: 219–227

Marth JD, Overell RW, Meier KE, Krebs EG and Perlmutter RM (1988) Translational activation of the lck proto-oncogene. Nature 332: 171–173

Nanbru C, Lafon I, Audigier S, Gensac MC, Vagner S, Huez G and Prats AC (1997) Alternative translation of the proto-oncogene c-myc by an internal ribosome entry site. J Biol Chem 272: 32061–32066

Nathan CA, Liu L, Li BD, Abreo FW, Nandy I and De Benedetti A (1997) Detection of the proto-oncogene eIF4E in surgical margins may predict recurrence in head and neck cancer. Oncogene 15: 579–584

Nielsen FC, Ostergaard L, Nielsen J and Christiansen J (1995) Growth-dependent translation of IGF-II mRNA by a rapamycin-sensitive pathway. Nature 377: 358–362

O'Keefe EJ, Chiu ML and Payne Jr RE (1988) Stimulation of growth of keratinocytes by basic fibroblast growth factor. J Invest Dermatol 90: 767–769

Ray BK, Lawson TG, Kramer JC, Cladaras MH, Grifo JA, Abramson RD, Merrick WC and Thach RE (1985) ATP-dependent unwinding of messenger RNA structure by eukaryotic initiation factors. J Biol Chem 260: 7651–7658

Rhoads RE (1993) Regulation of eukaryotic protein synthesis by initiation factors. J Biol Chem 268: 3017–3020

Rosenwald IB, Lazaris-Karatzas A, Sonenberg N and Schmidt EV (1993) Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E. Mol Cell Biol 13: 7358–7363

Ruan H, Shantz LM, Pegg AE and Morris DR (1996) The upstream open reading frame of the mRNA encoding S-adenosylmethionine decarboxylase is a polyamine-responsive translational control element. J Biol Chem 271: 29576–29582

Satyamoorthy K, Oka M and Herlyn M (2000) An antisense strategy for inhibition of human melanoma growth targets the growth factor pleiotrophin. Pigment Cell Res 13: Suppl 8 87–93

Sonenberg N (1996) mRNA 5′ cap-binding Protein eIF-4E and control of cell growth. In: Translational Control, Hershey JWB, Mathews MB, Sonenberg N (eds) pp. 245–269, Cold Spring Harbor: Cold Spring Harbor Laboratory Press

Thomas PS (1980) Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc Natl Acad Sci USA 77: 5201–5205

Vagner S, Gensac MC, Maret A, Bayard F, Amalric F, Prats H and Prats AC (1995) Alternative translation of human fibroblast growth factor 2 mRNA occurs by internal entry of ribosomes. Mol Cell Biol 15: 35–44

Willis A (1999) Translational control of growth factor and proto-oncogene expression. Int J Biochem Cell Biol 31: 73–86

Yew N, Strobel M and Van de Woude GF (1993) Mos and the cell cycle: the molecular basis of the transformed phenotype. Curr Opin Genet Dev 3: 19–25

Zimmer SG, DeBenedetti A and Graff JR (2000) Translational control of malignancy: the mRNA cap-binding protein, eIF-4E, as a central regulator of tumor formation, growth, invasion and metastasis. Anticancer Res 20: 1343–1351